Cadrenal Therapeutics, Inc. CVKD
1.06 USD -0.07 (-6.19%)
At closeNov 4, 2026, 4:00 PM EST
1.06 0.00 0.00%
After hours · Nov 4, 4:00 PM ET
1.05 Day range 1.15
0.816 52-week range 13.11
- YTD
- -84.37%
- 1 year
- -91.20%
Held by funds
3 US ETFs and mutual funds hold CVKD · largest positions
Ownership
Held by insiders 34.06%
Held by institutions 4.75%
Float held by institutions 7.20%
Institutions 4
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Royal Bank of Canada | 0.00% | 25 | 356 | Sep 29, 2024 |
| Bank of America Corporation | 0.00% | 5 | 71 | Sep 29, 2024 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 0.19% | 3,216 | 45.86K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.07% | 1,109 | 15.81K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.06% | 923 | 13.16K | Oct 30, 2024 |
| Vanguard Extended Market Index Fund | 0.00% | 60 | 855 | Sep 29, 2024 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| MURPHY JOHN RAYMOND | Director | Purchase | Oct 4, 2023 | 614,792 |
| PHAM QUANG X | Chief Executive Officer | Stock Gift | Apr 9, 2024 | 6,275,000 |
| SZOT MATTHEW K | Chief Financial Officer | Stock Award(Grant) | Jan 23, 2023 | 500,000 |
| WILSON GLYNN | Director | Conversion of Exercise of derivative security | Jan 23, 2023 | 50,000 |